[Study of the effects of intravenous administration of a synthetic adrenaline derivative of 1-(4-oxy-phenyl)-1-oxy-2-N-butylamino-ethane sulphate in central and peripheral vascular diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D014652:Vascular Diseases / Q000188:drug therapy*
D004983:Ethanolamines
Studio degli effetti di un derivato adrenalinico di sintesi solfato di 1-(4-ossi-fenil)-1-oxxi-2-N-butilamino-etano per via endovenosa nelle vasculopatie centrali e periferiche.